Hoosier Cancer Research Network is excited to share that Reps for Research 2024 has raised $3,060, bringing our 7-year cumulative total to more than $26,000.

Reps for Research took place on March 3, 2024, as fundraiser for Hoosier Cancer Research Network (HCRN) led by Christopher A. Fausel, chairman of HCRN’s board of directors and oncology precision genomics pharmacist at the IU Simon Comprehensive Cancer Center. The event included Fausel’s participation in the Arnold Sports Festival Pump & Run 5K in Columbus, Ohio.

Fausel invited pledges in support of HCRN for every bench press “rep” he completed during the event, with a maximum of 30 “reps.” He not only met the 30-rep goal, but raised $102 per rep.  The donations received directly supported investigator-initiated research, which is central to HCRN’s vision and mission. Watch this video to see Fausel meet his goal.

We are thrilled to have been able to bring Reps for Research back after a three-year hiatus. This fundraiser has already made a meaningful impact, gaining the attention of Fox 59. Watch the news coverage here.

Reps for Research was created in 2015 by Fausel as a way to combine his passion for investigator-initiated research with his participation in the Arnold Sports Festival Pump & Run. After six years of participating in this challenge, it was put on hold due to the COVID-19 pandemic. Following a three-year break, Fausel was more ready than ever to get back in the action and jumpstart the fundraiser.

Fausel’s involvement in Reps for Research, both in its establishment and active participation, demonstrates his dedication and endorsement of the organization’s work to provide access to innovative cancer therapies within local communities.

About Hoosier Cancer Research Network:

Hoosier Cancer Research Network conducts innovative cancer clinical trials in collaboration with more than 100 academic and community clinical research sites across the United States. Our studies are designed by cancer researchers from our member institutions. The HCRN staff includes 55 team members who work together to support all aspects of the studies we manage, from the time we receive the initial concept from a researcher through the final publication of the study results. Currently, we are supporting more than 70 clinical trials across a wide range of cancer types. Over our 40-year history, more than 10,000 participants in have enrolled in our clinical trials, leading to important discoveries that help cancer patients live longer and better after their cancer diagnosis.